Shanxi Zhendong Pharmaceutical Co.,Ltd

The company was founded on October 1, 1993. Zhendong Group is a national innovative model enterprise, a national patent pilot unit, a national intellectual property advantage enterprise, a national enterprise technology center, an international joint research and demonstration enterprise, a national key leading enterprise in agricultural industrialization, the most innovative Chinese medicine enterprise in China, and the best industrial enterprise in the Chinese pharmaceutical research and development product line. It is a national civilized unit and has won many honors such as “National Advanced Grassroots Party Organization”, “National Advanced Poverty Alleviation Unit” and “China Charity Outstanding Contribution Unit”. The company's main business is research and development, production, and sales of generic pharmaceuticals and innovative drugs such as oncology, dermatology, digestion, urinary, mental and mental medicine, as well as the entire Chinese herbal medicine industry chain integrating seed nurturing, planting, processing, storage, and tablets. Main products: Minoxidil linimide, colloidal pectin bismuth capsules, trimebutine maleate capsules, bicalutamide capsules, abiraterone acetate tablets, injectable shiitake mushroom polysaccharide, injectable pemetrexed disodium, injectable amoxicillin sodium, injectable fucloxacillin sodium, injectable ceftriamidine, riboflavin phosphate for injections, vitamin C for injections, potassium chloride for injections, compound bitter ginseng injection, xihuang pills, sedative blood injections, and astragalanine injections Zhitongluo capsules, Shenbai Shuxin capsules, concussion tablets, spleen and kidney relief pills, Yinqiao Detox capsules, Hawthorn pills, etc. Corporate honors: It has won many honorary titles such as “National May 1st Labor Award”, “National Advanced Unit for Poverty Alleviation”, “Outstanding Contribution Unit for Chinese Philanthropy”, and “Advanced Unit for the Construction of Traditional Chinese Medicine Modern Science and Technology Industry Base”. The company won the title of “Top 100 Pharmaceutical Manufacturing Companies” in the list of the most influential Chinese pharmaceutical industry in the 2022 - 2023. The 29th batch of national enterprise technology centers released in 2023. The company's technology center was recognized as a “national enterprise center”, and is the only enterprise technology center in Shanxi Province that passed national certification in 2022. In 2023, the company's subsidiary, Shanxi Zhendongdi Herbal Medicine Development Co., Ltd. was awarded the national “Three Unique Benchmark Enterprise” by the Chinese Herbal Medicine Standardization and Quality Assessment Innovation Alliance.